Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality

Sarcopenia is an acknowledged risk factor for individuals with chronic liver disease, however, the influence on outcomes in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) remains underexplored.